Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Y-79 |
Human retinablastoma cell line | ATCC HTB-18 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Gao et al., Mol. Cell Biochem., 2016, 414:77-84; DOI 10.1007/s11010-016-2660-y | ||
Y-79 |
Human retinablastoma cell line | ATCC HTB-18 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Gao et al., Inc. J. Biochem. Mol. Toxicol., 2014, 28 :394-399, DOI 10.1002/jbt.21576 | ||
WI-38 |
Human lung fibroblast cells | ATCC CCL-75 | Human | respiratory system | unknown | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
WI-38 |
Human lung fibroblast cells | ATCC CCL-75 | Human | respiratory system | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
WERI-Rb1 |
Human retinoblastoma cell line | ATCC HBT-169 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Liang et al., Experimantal and Therapeutic Medicine, 2017, 14: 2367-2372, DOI: 10.3892/etm.2017.4779 | Link | |
WERI-Rb1 |
Human retinoblastoma cell line | ATCC HBT-169 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Liu et al., Pathology - Res. and Practice, 2019, 215, 152641, doi.org/10.1016/j.prp.2019.152641 | Link | |
UACC-257 |
Human melanoma cells | Human | skin | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Vamanet al., 2015, PLoS ONE 10(6): e0129219; doi:10.1371/journal.pone.0129219 | Link | ||
U937 |
Human histiocytic lymphoma cell line | ATCC CRL-1593.2 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Kim et al., Innate Immunity, Nov 2014; 20: 799 - 815. | ||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | U. Weirauch et al., Nucleic Acid Therapeutics, 2013, 23 (4): 264-272, DOI: 10.1089/nat.2012.0407 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | B. Li et al., ResearchSquare, 2020, doi.org/10.21203/rs.3.rs-58864/v1 | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S.-K. Kim et al., Cellular & Molecular Immunology, 2017, 14: 349-359 | Link | |
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Diaz-Moralli et al., Oncotarget, 2016, 7 (32): 51876-51897 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Guardavaccaro, Dissertation, 2012, Universita degli Studi della Tuscia | Link | |
T-24 |
Human urinary bladder cancer cell line | ATCC HTB-4 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Endres et al., Oncotarget, 2016, 7(39): 64244-64259 | Link | |
SKN-SH |
Human neuroblastoma cell line | ATCC HTB-11 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Yang et al., Mol. Neurobiol., 2016, 53:5833-5846; DOI 10.1007/s12035-015-9485-7 | ||
SKN-SH |
Human neuroblastoma cell line | ATCC HTB-11 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Yang et al., Mol. Neurobiol., 2017, 54:3476-3491 | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | N. Golkar et al., Int. J. of Pharmaceutics, 2016, 510: 30-41; doi.org/10.1016/j.ijpharm.2016.06.026 | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | N. Golkar et al., Data in Brief, 2016, 8:1018-1023; doi.org/10.1016/j.dib.2016.06.064 | Link | |
SK-N-SH |
Human neuroblastoma cell line | ATCC HTB-11 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | Z. Ping et al., Cell Cycle, 2012, 11: 10, 1999-2005, doi.org/10.4161/cc.20402 | Link | |
SK-MEL-3 |
Human skin malignant metastatic melanoma cell line | ATCC HTB-69 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 | ||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Kim et al., Mol. Cell Biol., 2015, 35:1754-1762; doi:10.1128/MCB.01325-14 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. Wanget al., Cell Mol. Neurobiol., 2016, 36:603-611; DOI 10.1007/s10571-015-0241-3 | ||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene | publication | S. Kim et al., Mol. Cell Biol., 2015, 35:1754-1762; doi:10.1128/MCB.01325-14 | Link | |
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Clinical and Translational Medicine, 2014, 3:1, doi:10.1186/2001-1326-3-1 | Link |